Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bordetella petrii clinical isolate.

ABSTRACT: We describe the first clinical isolate of Bordetella petrii from a patient with mandibular osteomyelitis. The only previously documented isolation of B. petrii occurred after the initial culture of a single strain from an environmental source.

SUBMITTER: Fry NK

PROVIDER: S-EPMC3371814 | biostudies-literature | 2005 Jul

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Bordetella petrii clinical isolate.

Fry Norman K NK Duncan John J Malnick Henry H Warner Marina M Smith Andrew J AJ Jackson Margaret S MS Ayoub Ashraf A

Emerging infectious diseases 20050701 7

We describe the first clinical isolate of Bordetella petrii from a patient with mandibular osteomyelitis. The only previously documented isolation of B. petrii occurred after the initial culture of a single strain from an environmental source. ...[more]

PMID: 16022798

Similar Datasets

Septic arthritis and osteomyelitis due to Bordetella petrii.

Project description:A case of Bordetella petrii septic arthritis and osteomyelitis in an elbow resulted from a dirt bike accident in Hawaii. Two months of intravenous antibiotics and repeated surgeries were required to cure this infection. Our case, and literature review, suggests that extended-spectrum penicillins, tetracycline, and trimethoprim-sulfamethoxazole are good treatment options.

| S-EPMC4390665 | biostudies-literature

Adaptability and persistence of the emerging pathogen Bordetella petrii.

Project description:The first described, environmentally isolated, Bordetella petrii was shown to undergo massive genomic rearrangements in vitro. More recently, B. petrii was isolated from clinical samples associated with jaw, ear bone, cystic fibrosis and chronic pulmonary disease. However, the in vivo consequences of B. petrii genome plasticity and its pathogenicity remain obscure. B. petrii was identified from four sequential respiratory samples and a post-mortem spleen sample of a woman presenting with bronchiectasis and cavitary lung disease associated with nontuberculous mycobacterial infection. Strains were compared genetically, phenotypically and by antibody recognition from the patient and from inoculated mice. The successive B. petrii strains exhibited differences in growth, antibiotic susceptibility and recognition by the patient's antibodies. Antibodies from mice inoculated with these strains recapitulated the specificity and strain dependent response that was seen with the patient's serum. Finally, we characterize one strain that was poorly recognized by the patient's antibodies, due to a defect in the lipopolysaccharide O-antigen, and identify a mutation associated with this phenotype. We propose that B. petrii is remarkably adaptable in vivo, providing a possible connection between immune response and bacterial evasion and supporting infection persistence.

| S-EPMC3672207 | biostudies-literature

Bordetella petrii infection with long-lasting persistence in human.

Project description:We report the repeated isolation of Bordetella petrii in the sputum of a 79-year-old female patient with diffuse bronchiectasis and persistence of the bacterium for >1 year. The patient was first hospitalized due to dyspnea, which developed into severe cough with purulent sputum that yielded B. petrii on culture. After this first episode, the patient was hospitalized an additional 4 times with bronchorrhea symptoms. The isolates collected were analyzed by using biochemical, genotypic, and proteomic tools. Expression of specific proteins was analyzed by using serum samples from the patient. The B. petrii isolates were compared with other B. petrii isolates collected from humans or the environment and with isolates of B. pertussis, B. parapertussis, B. bronchiseptica, and B. holmesii, obtained from human respiratory tract infections. Our observations indicate that B. petrii can persist in persons with chronic pulmonary obstructive disease as has been previously demonstrated for B. bronchiseptica.

| S-EPMC3377417 | biostudies-literature

Bordetella petrii

Project description:Bordetella petrii overview

| PRJNA36819 | ENA

Bordetella petrii J49

Project description:Bordetella petrii J49 Genome sequencing and assembly

| PRJNA202366 | ENA

Bordetella petrii J51

Project description:Bordetella petrii J51 Genome sequencing and assembly

| PRJNA202358 | ENA

Complete genome sequence of a clinical Bordetella pertussis isolate from Brazil.

Project description:There has been a resurgence in the number of pertussis cases in Brazil and around the world. Here, the genome of a clinical Bordetella pertussis strain (Bz181) that was recently isolated in Brazil is reported. Analysis of the virulence-associated genes defining the pre- and post-vaccination lineages revealed the presence of the prn2-ptxS1A-fim3B-ptxP3 allelic profile in Bz181, which is characteristic of the current pandemic lineage. A putative metallo-β-lactamase gene presenting all of the conserved zinc-binding motifs that characterise the catalytic site was identified, in addition to a multidrug efflux pump of the RND family that could confer resistance to erythromycin, which is the antibiotic of choice for treating pertussis disease.

| S-EPMC4296508 | biostudies-literature

Bordetella petrii strain:P3

Project description:Bordetella petrii strain:P3 Genome sequencing and assembly

| PRJNA986431 | ENA

Bordetella petrii strain:BMC_SI_3

Project description:Bordetella petrii strain:BMC_SI_3

| PRJNA708297 | ENA

Bordetella petrii strain:MY10

Project description:Bordetella petrii strain:MY10 Genome sequencing and assembly

| PRJNA782487 | ENA